Calata et al.
JOCArticle
230 [M þ H]þ (100), 210 (89); HRMS (ESI) m/z[Mþ H]þ calcd for
2-[[1-Fluoro-2-(1H-imidazol-1-yl)ethyl]sulfonyl]-1,3-benzothi-
azole (11). To a solution of 2-[(1-fluorovinylsulfonyl)]-1,3-ben-
zothiazole (8) (100 mg, 0.41 mmol, 1 equiv) in CH2Cl2 (8 mL) was
added imidazole (30 mg, 0.45 mmol, 1.1 equiv). The mixture was
stirred for 16 h at room temperature, quenched with a saturated
solution of NH4Cl (3 mL), and extracted with CH2Cl2 (2 ꢀ
10 mL). The combined organic layers were dried over MgSO4,
filtered, and evaporated under reduced pressure. The crude
product was purified by flash column chromatography (silica,
CH2Cl2 then CH2Cl2/AcOEt 90:10) to give 11 (100 mg, 76%) as a
C9H9FNOS2 230.0110, found 230.0102.
2-Benzothiazolylsulfonyl-2-fluoroethanol (5). To a solution of
sulfide 4 (2.00 g, 8.73 mmol, 1 equiv) in CH2Cl2 (22 mL) at 0 °C
was added dropwise a solution of m-CPBA (9.04 g, 52.40 mmol,
6 equiv) in CH2Cl2 (18 mL). The mixture was stirred for 48 h at
room temperature and washed with a saturated solution of
NaHCO3 (2 ꢀ 30 mL). Aqueous layers were extracted with
CH2Cl2 (2 ꢀ 50 mL), and the combined organic layers were
dried over MgSO4, filtered, and evaporated under reduced
pressure. The crude product was purified by flash column chro-
matography (silica, pentane/AcOEt 7:3) to afford 5 (1.60 g, 75%)
as a colorless solid: mp 123-125 °C; 1H NMR (CDCl3, 250 MHz)
1
white solid: mp 129 -132 °C; H NMR (CDCl3, 400 MHz) δ
4.59-4.93 (m, 2H), 5.82 (dd, 2JHF = 48.2 Hz, 3JHH = 8.5 Hz,
1H), 6.90 (d, 3JHF = 22.4 Hz, 2H), 7.51-7.77 (m, 3H), 7.96-7.98
(m, 1H), 8.14-8.16 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 44.4
3
δ 2.38 (s, 1H), 3.93-4.14 (m, 2H), 6.59 (dt, JHH = 4.0 Hz,
2JHF = 46.8 Hz, 1H), 7.18-7.43 (m, 2H), 7.73 (d, 3JHH = 8.0 Hz,
1H), 7.89 (d, 3JHH = 7.9 Hz, 1H); 13C NMR (CDCl3, 100 MHz)
δ 59.1 (d, 2JCF = 21.2 Hz), 101.4 (d, 1JCF = 225.4 Hz), 122.4,
125.8, 128.0, 128.7, 137.5, 152.6, 162.3; 19F NMR (CDCl3,
(d, JCF = 20.5 Hz), 99.7 (d, JCF = 227.4 Hz), 119.5, 122.4,
2
1
125.8, 128.2, 128.9, 130.5, 137.5, 137.8, 152.7, 161.1; 19F NMR
2
3
(CDCl3, 376 MHz) δ -179.0 (ddd, JFH = 48.2 Hz, JFH
=
30.9 Hz, 3JFH = 17.3 Hz); MS (EI) m/z 312 [M þ H]þ (100), 244
(85); HRMS (ESI) m/z [M þ H]þ calcd for C12H11FN3O2S2
312.0277, found 312.0276.
2
3
235 MHz) δ -185.4 (dt, JFH = 46.8 Hz, JFH = 18.8 Hz);
MS (EI) m/z 262 [M þ H]þ (100), 244 (10), 200 (20), 182 (73);
HRMS (ESI) m/z [M þ H]þ calcd for C9H9FNO3S2 262.0008,
found 261.9997.
2-[2-(1,3-Benzothiazol-2-ylsulfonyl)-2-fluoroethyl]phthalimide
(12). To a solution of phthalimide (80 mg, 0.53 mmol, 1.3 equiv)
in THF (2 mL) were added a 1 M solution of TBAF in THF
(410 μL, 0.41 mmol, 1 equiv) and 2-[(1-fluorovinylsulfonyl)]-
1,3-benzothiazole (8) (100 mg, 0.41 mmol, 1 equiv). The mixture
was stirred for 1 h at room temperature, quenched with a
saturated solution of NH4Cl (1 mL), and extracted with CH2Cl2
(2 ꢀ 5 mL). The combined organic layers were dried over
MgSO4, filtered, and evaporated under reduced pressure. The
crude product was purified by flash column chromatography
(silica, CH2Cl2/pentane 80:20) to afford 12 (100 mg, 61%) as a
2-[(1-Fluorovinyl)sulfonyl]-1,3-benzothiazole (8). To a solu-
tion of 2-benzothiazolylsulfonyl-2-fluoroethanol (5) (300 mg,
1.14 mmol, 1 equiv) and MsCl (110 μL, 1.38 mmol, 1.2 equiv)
in CH2Cl2 (4 mL) cooled to 0 °C was added dropwise NEt3
(400 μL, 2.85 mmol, 2.5 equiv). The mixture was stirred for
30 min at 0 °C and then quenched with a saturated solution of
NH4Cl (1 mL). The aqueous layer was extracted with CH2Cl2
(2 ꢀ 10 mL). Combined organic layers were washed with a
saturated solution of NaHCO3 (2 ꢀ 1 mL), dried over MgSO4,
filtered, and evaporated under reduced pressure to furnish pure
1
white solid: mp 166-168 °C; H NMR (CDCl3, 400 MHz) δ
1
8 (259 mg, 92%) as a white solid: mp 141-142 °C; H NMR
4.44-4.53 (m, 2H), 5.99 (ddd, 2JHF = 48.0 Hz, 3JHH = 8.3 Hz,
3JHH = 4.3 Hz, 1H), 7.48-7.61 (m, 2H), 7.66-7.69 (m, 2H),
(CDCl3, 250 MHz) δ 5.65 (dd, 2JHH = 5.0 Hz, 3JHF = 11.7 Hz,
1H), 6.06 (dd, 2JHH = 5.0 Hz, 3JHF = 40.7 Hz, 1H), 7.54-7.64
(m, 2H), 7.96-7.99 (m, 1H), 8.19-8.22 (m, 1H); 13C NMR
7.78-7.82 (m, 2H), 7.93-7.97 (m, 1H), 8.17-8.19 (m, 1H); 13
C
NMR (CDCl3, 100 MHz) δ 35.5 (d, 2JCF = 22.1 Hz), 97.5 (d,
1JCF = 226.8 Hz), 122.4, 123.8, 125.9, 128.0, 128.7, 131.6, 134.5,
137.5, 152.8, 161.5, 167.2; 19F NMR (CDCl3, 376 MHz) δ -182.8
(ddd, 2JFH = 48.0 Hz, 3JFH = 24.2 Hz, 3JFH = 14.3 Hz); MS (EI)
m/z 391 [M þ H]þ (65), 307 (28), 192 (100), 172 (9); HRMS (ESI)
m/z [M þ H]þ calcd for C17H12FN2O4S2 391.0223, found
391.0207.
(CDCl3, 100 MHz) δ 64.1 (d, 2JCF = 25.2 Hz), 99.5 (d, 1JCF
=
224.2 Hz), 121.2, 122.4, 125.2, 126.5, 136.0, 152.8, 161.3; 19F
2
NMR (CDCl3, 235 MHz) δ -114.2 (dd, JFH = 40.7 Hz,
3JFH = 11.7 Hz); MS (EI) m/z 244 [M þ H]þ (100), 214 (8),
158 (13), 141 (7), 99 (4); HRMS (ESI) m/z [M þ H]þ calcd for
C9H7FNO2S2 243.9902, found 243.9913.
General Procedure for the Preparation of Aliphatic Fluoro-
aminosulfones (10a-i). To a solution of 2-[(1-fluorovinylsulfonyl)]-
1,3-benzothiazole (8) (1 equiv) in CH2Cl2 was added aliphatic
amine (1.3 to 1.5 equiv). The mixture was stirred for 5 min at
room temperature then quenched with a saturated solution of
NH4Cl (3 mL). The aqueous layer was extracted with CH2Cl2
(2 ꢀ 10 mL). The combined organic layers were dried over
MgSO4, filtered, and evaporated under reduced pressure. The
crude product was purified by flash column chromatography to
give fluoroaminosulfones 10a-i.
2-[(1-Fluoro-2-pyrrolidin-1-ylethyl)sulfonyl]-1,3-benzothiazole
(10e). The general procedure was followed with 2-[(1-fluoro-
vinylsulfonyl)]-1,3-benzothiazole (8) (1 g, 4.11 mmol, 1 equiv),
pyrrolidine (440 μL, 5.34 mmol, 1.3 equiv), and CH2Cl2 (17 mL).
The purification by flash column chromatography (silica, pen-
tane/AcOEt 95:5 then 90:10) afforded 10e (1.23 g, 95%) as a
colorless solid: mp 73 -77 °C; 1H NMR (CDCl3, 250 MHz) δ
1.60-1.70 (m, 4H), 2.60-2.70 (m, 4H), 3.13-3.57 (m, 2H),
5.69-5.93 (m, 1H), 7.61-7.66 (m, 2H), 8.01-8.04 (m, 1H),
8.24-8.28 (m, 1H); 13C NMR (CDCl3, 62 MHz) δ 23.6, 52.5 (d,
2JCF = 19.5 Hz), 54.4, 101.7 (d, 1JCF = 225.2 Hz), 122.3, 125.7,
127.8, 128.3, 137.4, 152.7, 162.6; 19F NMR (CDCl3, 235 MHz) δ
-178.5 (ddd, 2JFH = 49.0 Hz, 3JFH = 31.5 Hz, 3JFH = 20.0 Hz);
MS (EI) m/z 315 [M þ H]þ (87), 244 (100), 180 (5), 116 (88), 84
(22); HRMS (ESI) m/z [M þ H]þ calcd for C13H16FN2O2S2
315.0637, found 315.0626.
General Procedure for the Preparation of Fluorinated Sulfo-
nylamino Acid Alkyl Esters (13a-f). To a solution of chlorhy-
drate amino acid alkyl ester (1 equiv) and NEt3 (3 equiv) in
MeCN were introduced 2-[(1-fluorovinylsulfonyl)]-1,3-ben-
zothiazole (8) (1 equiv) and silica (2 equiv w/w). The solution
was stirred under reflux for 4-6 h. The reaction mixture was
cooled to room temperature, hydrolyzed with a saturated solu-
tion of NH4Cl (1 mL), and extracted with CH2Cl2 (2 ꢀ 5 mL).
The combined organic layers were dried over MgSO4, filtered,
and evaporated under reduced pressure. The crude product was
purified on a short silica pad to give fluorinated sulfonylamino
acid alkyl esters 13a-f.
N-[2-(1,3-Benzothiazol-2-ylsulfonyl)-2-fluoroethyl]glycine
Ethyl Ester (13a). The general procedure was followed with
2-[(1-fluorovinylsulfonyl)]-1,3-benzothiazole (8) (100 mg, 0.41
mmol, 1 equiv), chlorhydrate glycine ethyl ester (60 mg, 0.41
mmol, 1 equiv), NEt3 (170 μL, 1.23 mmol, 3 equiv), and silica
(204 mg) for 4 h in refluxing MeCN (2 mL). The purification on
a short silica pad (CH2Cl2 then CH2Cl2/AcOEt 98:2 and
CH2Cl2/AcOEt 95:5) afforded 13a (100 mg, 69%) as a colorless
oil: 1H NMR (CDCl3, 400 MHz) δ 1.17 (t, 3JHH = 7.2 Hz, 3H),
1.94-1.95 (m, 1H), 3.37-3.52 (m, 4H), 4.09 (q, 3JHH = 7.2 Hz,
2H), 5.70 (ddd, 2JHF = 48.0 Hz, 3JHH = 7.4 Hz, 3JHH = 3.4 Hz,
1H), 7.53-7.58 (m, 2H), 7.93-7.95 (m, 1H), 8.15-8.17 (m, 1H);
13C NMR (CDCl3, 100 MHz) δ 13.1, 49.9 (d, 2JCF = 23.4 Hz),
54.4, 61.4, 102.6 (d, 1JCF = 212.7 Hz), 116.7, 120.4, 123.0, 124.9,
9404 J. Org. Chem. Vol. 74, No. 24, 2009